Clinical Trials Directory

Trials / Unknown

UnknownNCT05238168

Evaluation of Digital Follow up of Preterm Infants

ePIPARI - Digital Follow-up of Preterm Infants During First Two Years

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Turku University Hospital · Other Government
Sex
All
Age
1 Month – 28 Months
Healthy volunteers
Not accepted

Summary

The aim is to study how a digital follow up tool can identify the preterm born children and their families who need further support or clinical interventions

Detailed description

This study runs a digital follow up parallel to clinical follow up, up to 2 years of corrected age of the child. It evaluates the ability of the digital follow up tool to identify the problems in growth and health, eating and feeding, neurodevelopment and parental wellbeing which require further support or interventions. This study includes all infants born under 34 weeks of gestation in Turku University Hospital during years 2019-2022 and those preterm children born under 32 weeks of gestation who turn to 2 years during years 2019-2021. Parent satisfaction about the digital follow up tool is asked at each time point and anonymously once per year. The follow up age points are the expected day of birth, 1 month, 2 months, 4 months, 8 months, 12 months, 18 months and 24 months after the expected birth date.

Conditions

Interventions

TypeNameDescription
OTHERePIPARI digital follow up toolA digital platform includes questions to parents about child wellbeing and development and parent wellbeing. A notification by email or app comes two weeks before the follow up time point. The parents respond via a link to a webpage or via an app.They also receive information (text and video) about age-appropriate child development. ePIPARI includes 8 assessment points from term age until 2 years of corrected age.

Timeline

Start date
2019-01-01
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2022-02-14
Last updated
2022-04-19

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT05238168. Inclusion in this directory is not an endorsement.